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Canonical telomere repeats at chromosome termini can be main-
tained by a telomerase-independent pathway termed alternative
lengthening of telomeres (ALT). Human cancers that survive via
ALT can exhibit long and heterogeneous telomeres, although
many telomerase-negative tumors possess telomeres of normal
length. Here, we report that Caenorhabditis elegans telomerase
mutants that survived via ALT possessed either long or normal
telomere lengths. Most ALT strains displayed end-to-end chromo-
some fusions, suggesting that critical telomere shortening oc-
curred before or concomitant with ALT. ALT required the 9-1-1
DNA damage response complex and its clamp loader, HPR-17. De-
ficiency for the POT-2 telomere binding protein promoted ALT in
telomerase mutants, overcame the requirement for the 9-1-1 com-
plex in ALT, and promoted ALT with normal telomere lengths. We
propose that telomerase-deficient human tumors with normal
telomere lengths could represent a mode of ALT that is facilitated
by telomere capping protein dysfunction.
PROTECTION OF TELOMERES-2 | telomere maintenance
Telomeres are tandem repeat tracts that cap the ends of linearchromosomes and erode with each cell cycle because of the
inability of canonical DNA polymerases to completely replicate
chromosome termini (1). However, the ribonucleoprotein telo-
merase combats this erosion by adding de novo telomeric repeats
via reverse transcription (2). Progressive telomere shortening
during proliferation of human somatic cells can trigger senes-
cence, which serves as a major tumor suppression mechanism (3).
Bypass of senescence and further cell proliferation leads to critical
telomere shortening and crisis, resulting in high levels of cell death
due to chromosome instability (4). Many tumors overcome this
proliferation barrier by activating expression of the telomerase
reverse transcriptase. The remaining 10–15%of human tumors do
not possess telomerase activity (5, 6).
S. cerevisiae strains deficient for telomerase can survive with
long and heterogeneous telomeres composed of amplified telo-
mere repeats (type II survivors) (7, 8). Analogous to type II
survivors, long and heterogeneous telomeres occur in almost all
in vitro immortalized cell lines and tumor-derived cells lines that
are telomerase-negative (9–11). Furthermore, extensive analysis
of telomerase activity and telomere length from primary human
tumor samples has revealed that certain telomerase-negative
tumors possess long and heterogeneous telomeres, defined as
alternative lengthening of telomeres (ALT) tumors (9). How-
ever, the majority (81/108) of primary tumors lacking telomerase
activity have telomeres of normal lengths (9, 12–15). This subset
of telomerase-negative tumors may have become neoplastic be-
fore exhausting their telomere repeat reserves (9, 16). Alterna-
tively, these tumors could have evolved via the same telomere-
driven crisis events that give rise to ALT tumors, followed by
activation of a distinct form of ALT that maintains telomeres of
apparently normal lengths (9).
Homologous recombination proteins can promote survival in
the absence of telomerase. For example, S. cerevisiae type II sur-
vivors rely on theHRproteins RAD52 andRAD50 for survival (7,
8, 17). In human ALT cells, theMRN homologous recombination
complex and the structure-specific endonuclease MUS81, which
participates in resolution of recombination intermediates, are
required for telomere maintenance and cell survival (18, 19).
Recombination may play a role in generating an extrachromo-
somal telomeric repeat circle, which can be used as a template for
rapid telomere elongation via rolling circle replication (20, 21).
To gain a better understanding of ALT, we studied survivors of
telomerase deficiency inC. elegans.Weobserved that spontaneous
ALT survivors can have long and heterogeneous telomeres or
normal telomere lengths, or both. A DNA damage response
complex that promotes telomerase activity is required for ALT.
Lastly, deficiency for a telomere capping protein promotes amode
of ALT where telomeres are normal in length. These observations
suggest that ALT may occur in primary human telomerase-nega-
tive tumors that possess telomeres of normal lengths.
Results
Survivors of Telomerase Deficiency in C. elegans Can Have Normal
Telomere Lengths. To explore the possibility that mutations may
promote survival in the absence of telomerase in C. elegans, a trt-
1 unc-29 strain that has a deletion in the telomerase reverse
transcriptase, trt-1 (22), and a tightly linked mutation unc-29 that
serves as a visible marker for trt-1, was mutagenized with ethyl-
methanesulfonate (EMS) at generation F11 (23). The trt-1 unc-
29 animals used for this mutagenesis were all derived from
progeny of a single freshly outcrossed homozygous trt-1 unc-29
F2 hermaphrodite whose life began as a zygote with a diploid
complement of 24 telomeres, none of which are likely to have
been preexisting long telomeres (22). The mutagenized P0 her-
maphrodites, each harboring many EMS-induced mutations per
gamete, were singled and allowed to self-fertilize. Each P0 line
produced thousands of starved F2 animals homozygous for some
mutations derived from mutagenized P0 gametes. One hundred
and twenty EMS-mutagenized trt-1 unc-29 P0 lines and 40 non-
mutagenized sibling trt-1 unc-29 controls were established. Prior
experiments with this strain indicated that sterility would occur
as a consequence of telomerase deficiency within six generations
after mutagenesis, based on an assay where 6 L1 larvae per strain
were transferred every two generations (22).
To select for mutations that might promote ALT, agar chunks
containing hundreds of mutagenized (m) or control (c) animals
per trt-1 unc-29 strain were transferred monthly for two and
a half years, representing ≈40 additional generations. The
remaining strains were carefully examined for moderate re-
productive capacity, and candidate ALT strains were defined as
those where six nonstarved L4 larvae could produce 20–150
progeny. Initially, three strains of 120 initial mutagenized P0
plates and six strains of 40 nonmutagenized plates met these
criteria. After propagation for ≈225 additional generations by
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weekly chunking for >3 yr, only one mutagenized P0 strain sur-
vived, whereas five nonmutagenized control strains persisted,
suggesting that ALT may arise spontaneously and that EMS
mutagenesis may compromise survival via ALT.
To examine telomere length in the nine initial survivors,
Southern blots using a probe for the C. elegans telomere repeat
sequence (TTAGGC)n were performed (23). These strains
exhibited telomere sizes of <12 kb, typical for wild-type C. elegans
strains, and strains with long and heterogeneous telomeres of
>12 kb, both of which indicate telomerase-independent telomere
maintenance. Long and heterogeneous telomeres were accompa-
nied by telomeric DNA in the well, possibly corresponding to
complex telomeric structures recalcitrant to entering an agarose
matrix (Fig. 1A). Continued propagation of several survivor strains
with shorter telomeres (<12 kb) resulted in conversion to the long
and heterogeneous telomere phenotype in later generations (Fig.
1B; strains c3-1s, c1-2s, and c7-4s). Once established, the long and
heterogeneous telomere phenotype persisted for many generations,
rarely converting to the normal (<12 kb) telomeres lengths (Fig. 1
A–D; strains m9-3m and c1-2s). However, telomere lengths of some
ALT strains were normal (<12 kb) for many generations and dis-
played dynamics consistent with periods of continual shortening
accompanied by moderate or substantial bursts of telomere
lengthening (Fig. 1C; strain c8-2s). The c3-1s strain exhibited the
most telomere dynamics, switching continuously between normal
and long modes over the course of its propagation (Fig. 1 A–C).
Although ALT strains could be maintained by transferring
>100 animals per generation, these strains became sterile when
transferred via population bottlenecks of 6 or 10 animals per
generation, typically within 20 generations (Table S1). Southern
blotting revealed that small population bottlenecks resulted in
progressive telomere shortening, as observed for non-ALT trt-1
unc-29 telomerase mutants (Fig. 1E). Thus, ALT-based telomere
maintenance in C. elegans requires propagation of >100 animals
per generation and may depend on stochastic telomere amplifi-
cation events that occur in rare animals.
Critical telomere shortening can result in end-to-end chro-
mosome fusion in C. elegans telomerase mutants (22, 24). The
presence of end-to-end chromosome fusions in ALT strains was
assessed by scoring 4’,6-diamidino-2-phenylindole (DAPI)-posi-
tive spots in oocytes, where wild-type animals have six spots
corresponding to the haploid number of six C. elegans chromo-
somes (23). ALT strains commonly exhibited three or four spots,
and this number remained stable over many generations (Fig. 2
A–C and Table 1). Thus, critical telomere shortening and chro-
mosome end-to-end fusion likely occur before or concomitant
with induction of ALT, whereas stable karyotypes are main-
tained once ALT is established.
To more precisely quantify the ALT-based survival of unmu-
tagenized trt-1 unc-29 control strains observed above, we repeated
the initial experiment with 100 independent lines of trt-1 under
our ALT-favorable conditions where agar chunks containing
hundreds of nonmutagenized worms per strain were transferred
on a weekly basis (hereafter referred to as “large numbers of
worms”). Approximately 20% of the lines survived past 60 gen-
erations (=40 wk) (Fig. 3B), a growth period that is unattainable
for non-ALT trt-1 strains thatwere transferredweekly by passaging
6–10 L1 larvae (Fig. 3A). These new trt-1 ALT strains exhibited
long and heterogeneous or normal telomere lengths (Fig. 3C),
analogous to the results observed with the initial ALT strains (Fig.
1A andB).DAPI staining revealed that all newly derived trt-1ALT
strains displayed chromosome fusions at levels close to those ob-
served in the original trt-1 unc-29 ALT strains, which had been
passaged for many more generations (Table 2).
9-1-1 DNA Damage Checkpoint Response Complex Is Required for ALT.
Components of the 9-1-1 DNA damage checkpoint response
complex have been shown to associate with telomeric DNA in
human ALT cells (25, 26). The functional significance of the
DNA damage response proteins in ALT remains unclear and, in
mammals, is difficult to determine because the 9-1-1 complex is
essential for cell viability (27). Deficiencies for the C. elegans 9-1-
1 complex subunits, MRT-2 and HUS-1, and the clamp loader
HPR-17, result in viable strains that are defective for telomerase-
mediated telomere repeat addition in vivo (23, 28, 29). These
mutants can survive for many generations before becoming
sterile as a consequence of critical telomere shortening and end-
to-end chromosome fusion.
We propagated mrt-2 and hpr-17 mutants, including a newly
identified allele of hpr-17, yp7 (Fig. S1), in parallel with trt-1
control strains where large numbers of worms were transferred
to assess ALT-mediated survival in the absence of telomerase-
mediated telomere repeat addition. Approximately 20% of trt-1
control strains yielded survivors after 40 generations of growth,
whereas all mrt-2 and hpr-17 strains became sterile by this time
Fig. 1. Telomere dynamics of trt-1 ALT survivors. Terminal restriction
fragment analysis by Southern blotting of DNA from ALT survivors at ≈F120
(A) and ≈F220 (B). (C) Representative ALT strains exhibit normal telomeres
(c8-2s and c3-1s) or long and heterogeneous telomeres (c1-2s). (D) ALT strain
m9-3m exhibits long ALT telomeres and heterogeneous, shortening telo-
meres. (E) ALT survivors exhibit telomere shortening when passaged by
transferring 10 L1 larvae every two generations. Dashed lines to the right of
each blot correspond to internal telomere sequence tracts.
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(Fig. 3B; n = 100 strains each). Given that the telomeres of mrt-
2, hpr-17, and trt-1 single mutants erode at similar rates to those
of trt-1; mrt-2 and trt-1; hpr-17 double mutants (22, 28), the lack
of survivors for mrt-2 and hpr-17 suggests that the 9-1-1 complex
is required for ALT in C. elegans.
POT-2 Represses a Distinct Form of ALT with Telomeres of Normal
Lengths. The C. elegans genome harbors four genes that encode
homologs of mammalian Protection Of Telomeres 1 (POT1),
a protein that binds single-stranded telomeric DNA via two oli-
gosaccharide/oligonucleotide (OB) folds, OB1 and OB2 (30–32).
C. elegans MRT-1, a dual-domain protein comprised of an OB2
fold fused to an interstrand cross-link repair domain, is required for
telomerase-mediated telomere repeat addition in vivo (31),
whereas worms lacking POT-3, which also harbors an OB2 fold,
exhibit wild-type telomeres (32).Twoadditional POT1genes, pot-1
(also known as CeOB2) and pot-2 (also known as CeOB1), which
encode OB1 and OB2 folds, respectively, have been shown to
display elongated telomereswhenmutated (24, 32).Moreover,pot-
1 mutants possess heterogeneous telomeres similar to those ob-
served in human ALT cells (32). To test the hypothesis that pot-1
may promote ALT, we constructed the double mutant strains trt-1;
pot-1, trt-1; pot-2, and trt-1; pot-3 using well-outcrossed pot-1, pot-2,
or pot-3mutant backgrounds that possessed telomeres of wild-type
lengths. The double mutant strains were passaged each week by
chunking large number of worms (n= 100 lines per strain) and by
picking population bottlenecks of 10 L1 larvae per strain (n= ≈30
lines per strain). After 70 generations of growth where large
numbers of worms were transferred, trt-1; pot-1 and trt-1; pot-3
doublemutants displayed similar survival frequencies to trt-1 single
mutants, ≈20%, whereas trt-1; pot-2 strains exhibited a threefold
increase in survivorship, ≈65% (Fig. 3B). In contrast, population
bottlenecks of 10 larvae every two generations yielded very few or
no survivors for these strains (Fig. 3A). Thus, deficiency for pot-2
rather than pot-1 enhances the frequency of ALT where large
numbers of worms were transferred. However, trt-1; pot-1 ALT
strains typically displayed five DAPI-positive spots in oocytes, in
contrast to four spots in trt-1 or trt-1; pot-2 ALT strains (Table 2).
We confirmed that the reduced number of DAPI-positive spots in
four independent trt-1; pot-1 ALT strains likely occurred as a con-
sequence of X-autosome telomere-telomere fusions by demon-
strating genetic linkage between the left end of the X chromosome
and a dominant chromosome nondisjunction phenotype caused by
chromosome fusions present in these strains (Fig. S3) (23, 24).
Thus, pot-1 deficiency may modestly reduce the frequency of end-
to-end chromosome fusion in ALT strains. This result could in-
dicate a role forwild-typepot-1 in genesis of chromosome fusions in
the absence of telomerase. Alternatively, induction of ALT could
bemore efficient when it occurs in trt-1; pot-1 doublemutants, such
that fewer chromosome fusions occur, even though the frequency
of ALT is not increased.
Seventy percent of the trt-1 and trt-1; pot-1 survivors exhibited
telomeric signals >20 kb, accompanied by signals in the well,
whereas the remaining survivors had telomeres of short or normal
lengths (Fig. 3 C and D and Fig. S2). In contrast, 18/18 trt-1; pot-2
strains possessed telomeres that were predominantly short or
normal in length (Fig. 3D and Fig. S2). Although longer telomeres
were observed in some trt-1; pot-2 strains, they were shorter than
the large bands (>20 kb) observed in trt-1 and trt-1; pot-1 strains
with long and heterogeneous telomeres (Fig. 3D). The increase in
the frequency of trt-1; pot-2 survivors, and their shorter telomere
lengths, support a role for pot-2 deficiency in promoting a mode of
ALT that is distinct from that associated with long and heteroge-
neous telomeres in telomerase-negative human tumors.
Deficiency for pot-2 Allows for ALT in the Absence of the 9-1-1
Complex. Because the 9-1-1 complex is required for ALT in C.
elegans, we asked whether it is also required for the predominantly
short telomere form of ALT that occurs when pot-2 is deficient.
Although all pot-2; mrt-2 strains became sterile when propagated
in small population bottlenecks (Fig. 3A), ≈90% of the lines sur-
vived past 60 generations when transferred using large numbers of
worms per strain (Fig. 3B). Southern blotting revealed a lack of
long telomeric signals for pot-2; mrt-2ALT strains, confirming that
pot-2 deficiency may promote a specific type of ALT with telo-
meres of normal lengths (Fig. 3E). Normal telomere length was
maintained over the course of 20–40 generations for all seven pot-2;
mrt-2 strains examinedand for six trt-1; pot-2 strainsA,B,C,D,F, and
G, although the trt-1; pot-2 E strain switched from normal telomere
length to long and heterogeneous telomeres (Fig. 3 F andG).
Because deficiency for the POT-2 telomere binding protein
eliminates the requirement of mrt-2 for survival where large
numbers of worms were transferred, the lack of survivors in strains
deficient for the 9-1-1 complex or its clamp loader HPR-17 is al-
most certainly due to the inability of critically shortened telomeres
to initiate ALT, as opposed to deficiency for a telomere-in-
dependent function of the 9-1-1 complex or HPR-17, such as
responding to DNA damage. In addition, the sterility phenotypes
of mrt-2 and hpr-17 have been addressed in detail and are fully
consistent with resulting from telomerase-dependent telomere re-
peat addition defects (22, 23, 28). Note that although mrt-2 is re-
quired for telomerase-mediated telomere repeat addition in vivo
(22), trt-1 is wild type in mrt-2 strains, and we cannot exclude the
possibility that mutation of pot-2 allows for infrequent stochastic
Fig. 2. ALT strains harbor end-to-end chromo-
some fusions. DAPI photos of representative oo-
cyte nuclei for trt-1 survivors exhibit three
chromosomes (A and B) or two chromosomes (C).
mrt-2; pot-2 survivors exhibit five chromosomes
(D and E) or a wild-type complement of six chro-
mosomes (D and F). Dashed lines surround chro-
mosomes of individual oocyte nuclei. Wild-type oocytes uniformly display six DAPI-positive spots, comparable to F (22, 23, 28).
Table 1. Reduced chromosome numbers in late-generation ALT survivors
Strain F40 F50 F80 F220
wildtype 6.0 ± 0.0 (n = 13) ND ND ND
c1-1s 3.9 ± 0.4 (n = 21) 2.8 ± 0.4 (n = 19) 3.0 ± 0.4 (n = 20) 2.8 ± 0.4 (n = 15)
c1-2s 3.8 ± 0.5 (n = 20) 2.9 ± 0.3 (n = 18) 2.9 ± 0.3 (n = 14) 2.9 ± 0.3 (n = 15)
c3-1s 3.8 ± 0.4 (n = 24) 2.8 ± 0.4 (n = 22) 2.9 ± 0.4 (n = 20) 2.9 ± 0.3 (n = 15)
c5-2s 2.9 ± 0.3 (n = 16) 3.1 ± 0.1 (n = 20) 3.0 ± 0.0 (n = 10) ND
c7-4s 4.2 ± 0.6 (n = 15) 3.0 ± 0.2 (n = 20) 2.9 ± 0.3 (n = 14) 3.1 ± 0.4 (n = 17)
m3-4l 4.8 ± 0.5 (n = 19) 2.7 ± 0.5 (n = 18) 2.9 ± 0.4 (n = 16) ND
m9-3m 4.8 ± 0.4 (n = 27) 2.9 ± 0.2 (n = 17) 3.0 ± 0.0 (n = 16) 2.8 ± 0.4 (n = 18)
Whole worms were stained with DAPI, and condensed chromosomes were counted in the nuclei of 3–5
oocytes per worm in the indicated number of worms.






access of telomerase to telomeres, thereby promoting survival only
where large numbers of worms were transferred. However, because
pot-2; mrt-2 strains fail to survive when subjected to population
bottlenecks, and because trt-1; pot-2 strains display properties in
common with pot-2; mrt-2 strains, such as a high frequency of
survival where large numbers of worms were transferred, and
maintenance of predominantly normal telomere lengths (Fig. 3),
we favor the possibility that late-passage pot-2; mrt-2 strains sur-
vived via ALT when large numbers of worms were transferred.
DAPI staining of pot-2; mrt-2 survivors revealed that few
chromosome fusion events had occurred in these strains (Fig.
2D), many of which displayed a wild-type karyotype of six DAPI-
positive spots (Table 2 and Fig. 2 E and F). Thus, when pot-2 is
deficient, MRT-2 may inhibit the efficiency of ALT induction,
because chromosome fusions occur in trt-1; pot-2 ALT strains but
rarely in pot-2; mrt-2 ALT strains.
Discussion
Here, we demonstrate that telomeres of a multicellular organism
can be maintained indefinitely in the absence of telomerase.
C. elegans ALT strains arise spontaneously at frequencies that can
be manipulated by several proteins known to function in telomere
Fig. 3. pot-2 deficiency promotes a type of ALT with a distinct shorter telomere signature. (A) trt-1 or the 9-1-1 complex single mutants, as well as pot-1 or
pot-2 double mutants, become sterile if passaged by transferring 10 larvae weekly (n = roughly 30 strains per genotype, two generations per week). (B) Single
and double mutant strains can survive if chunked weekly (n = 100 plates per genotype, one and a half generations per week). (C) New trt-1 (ok410) ALT
survivors exhibit both long and normal telomeres. (D) Generation F60 trt-1; pot-2 survivors exhibit normal-length telomeres, whereas trt-1; pot-1 survivors
exhibit predominantly long telomeres. (E) Generation F30 pot-2; mrt-2 strains survive exclusively with normal length telomeres. (F and G) Telomere length
maintenance as ALT strains are propagated. Dashed bars to the right of each blot correspond to internal telomere sequence tracts.
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biology. Telomeres of normal lengths were observed in several
spontaneous trt-1 ALT strains. Deficiency for the POT-2 telomere
protein in either trt-1 or mrt-2 telomerase-defective backgrounds
yielded ALT strains with distinctly normal telomere lengths. We
propose that telomerase-negative human tumors with telomeres of
normal lengths may represent this distinct form of ALT (9), some
of which could arise as a consequence of mutations in genes that
encode telomere-binding proteins.
Telomerase-independent telomere maintenance that results in
telomeres of normal length has been reported for primary and
lymphoma cells from mouse telomerase RNA mutants (33), al-
though other studies have revealed long and heterogeneous
telomeres in mouse tumors derived in the context of telomerase
deficiency (34, 35). One immortalized human cell line, C3-cl6,
maintained short and homogeneous telomeres in the absence of
telomerase (10). These studies, in addition to many telomerase-
negative tumors that have been shown to lack long and hetero-
geneous telomeres (9, 12–15), support the prospect of an ALT
mechanism where telomeres are normal in length rather than
long and heterogeneous.
ALT is overrepresented in certain tumors, suggesting that a
specific developmental program or cellular niche may promote
ALT (16, 36). However, little is known about the genetic basis for
ALT in human tumors (37). In yeast, the absence of telomere
proteins Rif1 or Rif2, which normally repress telomerase activity,
has been shown to promote survival of telomerase-deficient strains
with long and heterogeneous telomeres (38). Of two C. elegans
POT1-related genes that exhibit elongated telomeres when ab-
sent, pot-1 and pot-2 (24, 32), we show that deficiency for pot-2
specifically promotes the frequency of survival via ALT, whereas
deficiency for pot-1 results in ALT strains that possess fewer
chromosome fusions. These results agree with a previous report
suggesting that pot-1 and pot-2 have overlapping but distinct bi-
ological functions (32). The high frequency of trt-1; pot-2 survivors
is consistent with a role for the POT-2OB2 fold protein in binding
and protecting the 3′ end of a chromosome (32), where ALT could
initiate by engaging an illegitimate replication or recombination
mechanism (Fig. 4A). In addition, ALT strains deficient for pot-2
hadpredominantly normal telomere lengths, suggesting that POT-
2 could promote bursts of ALT activity that lead to long and het-
erogeneous telomeres, or that it may function to repress trimming
of long telomeres (Fig. 4A), which is a natural process that can act
on ALT and non-ALT telomeres alike (39).
The 9-1-1 complex and HPR-17 represent a DNA polymerase
processivity factor and its clamp loader, which could physically
associate with critically shortened telomeres to fulfill their role in
telomerase-independent telomere maintenance. The homologous
recombination function of these proteins (40) may promote ALT,
possibly by facilitating the association of critically shortened
telomeres with recombination proteins that have been implicated
in ALT in diverse organisms (41). POT-2 may normally repress
a recombination or replication intermediate that channels criti-
cally shortened telomeres into the ALT telomere maintenance
mechanism, thereby promoting ALT in the absence of the 9-1-1
complex (Fig. 4B). We conclude that POT-2 functions not only to
repress ALT, but also to promote long and heterogeneous telo-
meres once the ALT pathway is engaged (Fig. 4).
The presence of chromosome fusions in most C. elegans sur-
vivors suggests that ALT initiation could be an inefficient pro-
cess, even for trt-1; pot-2 strains that display a threefold increase
in the frequency of ALT. Alternatively, the fusion process itself,
or associated levels of DNA damage signaling, may play critical
roles in initiation of ALT, which is supported by a model that
ALT acts on critically shortened telomeres in S. cerevisiae (8).
Consistent with this concept, human ALT cells can be derived
in vitro only if senescence is bypassed and cells reach crisis,
where critically shortened telomeres and chromosome fusions
are abundant (9, 16). Because our ALT-favorable conditions
required transferring large numbers of animals in all back-
grounds, induction and maintenance of ALT may rely on rare
Fig. 4. ALT pathway models. (A) POT-2 inhibits induction of ALT and could
either repress trimming of long ALT telomeres or promote conversion to
long and heterogeneous telomeres. (B) The 9-1-1 complex promotes ALT via
a mechanism that may be repressed by POT-2.
Table 2. Telomeric fusions in ALT survivors
Wildtype Original trt-1 New trt-1 trt-1;pot-2 trt-1;pot-1 pot-2;mrt-2
6.0 ± 0.0 (n = 25) 2.8 ± 0.4 (n = 15) 3.8 ± 0.4 (n = 13) 3.9 ± 0.3 (n = 9) 4.8 ± 0.4 (n = 13) 5.8 ± 0.4 (n = 11)
2.9 ± 0.3 (n = 15) 3.9 ± 0.3 (n = 13) 4.2 ± 0.4 (n = 13) 5.2 ± 0.4 (n = 13) 5.1 ± 0.3 (n = 13)
2.0 ± 0.3 (n = 15) 4.1 ± 0.5 (n = 14) 4.4 ± 0.5 (n = 13) 4.9 ± 0.3 (n = 13) 5.4 ± 0.7 (n = 11)
3.1 ± 0.4 (n = 17) 3.3 ± 0.5 (n = 14) 4.3 ± 0.5 (n = 12) 4.2 ± 0.4 (n = 17) 6.0 ± 0.0 (n = 11)
2.8 ± 0.4 (n = 18) 3.8 ± 0.4 (n = 13) 4.1 ± 0.4 (n = 15) 4.9 ± 0.2 (n = 17) 5.7 ± 0.5 (n = 14)
4.2 ± 0.4 (n = 13) 4.1 ± 0.3 (n = 11) 4.9 ± 0.4 (n = 14) 5.5 ± 0.5 (n = 11)
3.9 ± 0.4 (n = 14) 4.0 ± 0.0 (n = 14) 4.9 ± 0.5 (n = 15) 5.0 ± 0.4 (n = 12)
3.2 ± 0.4 (n = 12) 4.7 ± 0.5 (n = 18) 4.9 ± 0.4 (n = 14) 5.8 ± 0.4 (n = 13)
3.9 ± 0.4 (n = 14) 4.0 ± 0.4 (n = 14) 4.2 ± 0.4 (n = 17) 5.8 ± 0.4 (n = 11)
3.9 ± 0.3 (n = 10) 3.9 ± 0.3 (n = 12) 5.0 ± 0.0 (n = 12) 6.0 ± 0.0 (n = 14)
4.0 ± 0.0 (n = 10) 4.2 ± 0.4 (n = 16) 4.9 ± 0.3 (n = 10) 6.0 ± 0.0 (n = 12)
4.0 ± 0.0 (n = 6) 4.8 ± 0.4 (n = 16) 5.7 ± 0.5 (n = 10)
4.1 ± 0.4 (n = 15) 6.0 ± 0.0 (n = 10)
4.0 ± 0.0 (n = 10) 6.0 ± 0.0 (n = 12)
4.0 ± 0.0 (n = 12) 5.9 ± 0.3 (n = 13)
5.8 ± 0.4 (n = 12)
6.0 ± 0.0 (n = 12)
5.8 ± 0.4 (n = 13)
Whole worms were stained with DAPI, and condensed chromosomes were counted in the nuclei of 3–5 oocytes in the indicated
number of worms. Results for individual strains are presented.






stochastic events. The striking lack of chromosome fusions in
pot-2; mrt-2 ALT strains suggests that ALT initiation is more
efficient when it occurs in this background, perhaps acting
readily on a single initial critically shortened telomere (Fig. 4).
However, ALT is not constitutively active in mrt-2; pot-2 strains,
which become sterile because of telomere dysfunction if propa-
gated by transferring small numbers of worms (Fig. 3A).
Further analysis of ALT mechanisms may provide deeper in-
sight into the status of telomere maintenance in tumors, which
can serve as a prognostic marker for patients (12) and may guide
studies relevant to the etiology and treatment of telomerase-
negative cancers.
Materials and Methods
Strains. All experiments were conducted at 20 °C under standard culture
conditions. The following mutations were used in this study: dpy-5(e61) I, trt-
1(ok410) I, unc-29(e193) I, rol-6(e187) II, rol-1(e91) II, hpr-17(tm1579) II, hpr-
17(yp7) II, pot-2(tm1400) II, unc-52(e444) II, pot-1(tm1620) II, unc-32(e189) III,
dpy-18(e364) III, mrt-2(e2663) III, pot-3(ok1530) III, unc-64(e246) III. pot-1
(tm1620) and pot-2(tm1400) deletion mutations were outcrossed 15 times
versus unc-32 or unc-52 marker mutations, which had been crossed three
times versus an N2 ancestral male stock. Double mutant strains were then
constructed by using dpy-5 unc-29, unc-52, unc-32, dpy-18, or unc-64 as
balancers for trt-1, pot-2, pot-1, mrt-2, or pot-3, respectively. Briefly, trt-1;
unc-52, trt-1; unc-32, trt-1; unc-64 or trt-1; dpy-18 strains were crossed with
dpy-5 unc-29; pot-2, dpy-5 unc-29; pot-1, dpy-5 unc-29; pot-3, or dpy-5 unc-
29; mrt-2 triple mutant strains, respectively, where the latter pot triple
mutant strains were freshly constructed from well-outcrossed pot/+ het-
erozygous males and, therefore, contained wild-type telomere lengths. All
genotypes were confirmed by PCR of deletion mutations for trt-1, pot-2,
pot-1, or pot-3, or scoring radiation hypersensitivity for mrt-2 (23, 28).
Isolation of ALT Survivors. When telomerase-deficient C. elegans mutants are
passaged by using the standard Mortal Germline assay developed in our
laboratory, which involves passaging six animals to fresh plates weekly,
100% become sterile within 15–30 generations. When trt-1(ok410) strains
were passaged, weekly or monthly where indicated, by transferring a 0.5
cm × 0.5 cm chunk of agar populated with ≈150–400 animals, ≈20% of the
strains survived for hundreds of generations. For initial survivor experiments
comparing mutagenized versus nonmutagenized trt-1 strains, a trt-1(ok410)
unc-29 double mutant strain was used, where the trt-1 deletion ok410 is
tightly linked to the marker mutation unc-29.
Telomere Restriction Fragment Length Analysis. C. elegans genomic DNA was
digested with HinfI (New England Biolabs), separated on a 0.6% agarose gel
at 1.5 V/cm, and transferred onto a neutral nylon membrane (Hybond-N; GE
Healthcare Life Sciences). A digoxigenin-dUTP-labeled telomere probe was
hybridized and detected as described (23, 28).
DAPI Staining. Adult worms were suspended in an ethanol solution of DAPI
(150 μL, 400 ng/mL), and the solution was allowed to evaporate over 30 min.
Worms were rehydrated in 2 mL of M9 at 4 °C overnight, mounted in NPG/
glycerol medium (23, 28), and scored with a Nikon Eclipse E800 microscope.
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